Clinical Trial Update: Proteogenomic Signatures Analysis In Ovarian Cancer [NA]

View source ↗

Summary

A clinical trial update focusing on proteogenomic signatures analysis in ovarian cancer, with the study listed as active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Ovarian Cancer | NA | Status: ACTIVE_NOT_RECRUITING